Pancreatic Cancer Research

ResearcherZhejiang Cancer HospitalNo recent work listed

Jinxiao Liang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7987-6432; OpenAlex author ID A5101916479. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition. Co-author DOI 10.1021/acsomega.1c02945↗
  2. Ubiquitin‑specific protease 22‑induced autophagy is correlated with poor prognosis of pancreatic cancer. Co-author DOI 10.3892/or.2014.3508↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lisong Teng · 1 shared paper, 2021 · strength 0.17
  2. Liang Wang · 1 shared paper, 2021 · strength 0.17
  3. Weitian Wei · 1 shared paper, 2021 · strength 0.17
  4. Zhongyu Wang · 1 shared paper, 2014 · strength 0.04
  5. Zhen Ning · 1 shared paper, 2014 · strength 0.04
  6. Aman Wang · 1 shared paper, 2014 · strength 0.04
  7. Haifeng Luo · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.